• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL REVIVE - THROMBECTOMY DEVICE; MICRUS THROMBECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL REVIVE - THROMBECTOMY DEVICE; MICRUS THROMBECTOMY Back to Search Results
Catalog Number FRS21452299
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/08/2015
Event Type  malfunction  
Manufacturer Narrative
On (b)(6) 2015: ct scan aspect score for anterior circulation: 8 pre-procedure modified rankin score: 0, pre-procedure nihss score: 22 pre-procedure tici score: 0 post revive se tici score: 1 end of procedure tici score: 2b.(b)(4).Complaint conclusion: the device was not available for analysis.A review of the manufacturing documentation associated with this lot presented no issues during the manufacturing or inspection process that can be related to the reported complaint.Continued occlusion is a known procedural complication associated with thrombectomy devices.Based on the information provided, and no product return for analysis, it is not possible to definitively determine the root cause of the partial thrombectomy.Since the thrombus was finally removed with a larger stent, thrombus characteristics may have contributed to the event.There was no evidence provided to suggest the event was related to a manufacturing issue; therefore, no corrective actions will be taken at this time.Revive se is not marketed in the united states, but is similar to revive pv that is marketed in the united states.This is an initial/final mdr report.
 
Event Description
As reported via the re-act study, partial thrombectomy was achieved during use of the revive se (catalog/lot unk).At the time of the index procedure, after two passes to clear the clot with the revive se (frs214522-99/ t10066) resulting in partial thrombectomy, the basket was reconstrained in the microcatheter and removed.Thrombectomy was completed with use of a trevo 6mm and a solitaire 4mm.Tici score post revive se was 1, and tici score at end of the procedure was 2b.The following day, imaging revealed non-symptomatic intracranial hemorrhage near the treatment vessel, and the nihss score was 21.According to the investigator, the hemorrhage was not related to the revive, but was related to punctiform bleeding due to large ischemic core.Prior to the procedure, the patient had presented with symptoms consistent with ischemic stroke, and a 15mm left middle cerebral artery (m1) thrombus.Pre-procedure modified rankin score was 0, nihss score was 22, tici score was 1, and ct scan aspect score for anterior circulation 8.The diameter of the artery distal to the thrombus was 1.2mm, and diameter of the artery proximal to the thrombus was 2mm.The patient was initially treated with iv lytic (rt-pa 63mg/kg) and syringe aspiration.There had been no difficulty in getting the revive se through the clot, and the device was used and performed as per the instructions for use.The event did not result in a clinically significant delay in the procedure, since the device was quickly exchanged for a larger stent.According to the investigator, the revive se partial thrombectomy was possibly related to the revive se, but not serious.The patient was discharged to a re-education center due to right hemiplegia approximately 2 weeks after the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REVIVE - THROMBECTOMY DEVICE
Type of Device
MICRUS THROMBECTOMY
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel
SZ 
Manufacturer Contact
kimberly soter
821 fox lane
san jose, CA 95131
5088288310
MDR Report Key5402184
MDR Text Key37785231
Report Number2954740-2016-00029
Device Sequence Number1
Product Code DXE
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Type of Report Initial
Report Date 01/07/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/01/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2018
Device Catalogue NumberFRS21452299
Device Lot NumberT10066
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/07/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/04/2015
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Age36 YR
Patient Weight63
-
-